| Assessing the economic impact of adverse drug effects R Rodriguez-Monguio, MJ Otero, J Rovira Pharmacoeconomics 21, 623-650, 2003 | 288 | 2003 |
| Incentives for orphan drug research and development in the United States E Seoane-Vazquez, R Rodriguez-Monguio, SL Szeinbach, J Visaria Orphanet journal of rare diseases 3, 1-7, 2008 | 199 | 2008 |
| Market withdrawal of new molecular entities approved in the United States from 1980 to 2009 ZP Qureshi, E Seoane‐Vazquez, R Rodriguez‐Monguio, KB Stevenson, ... Pharmacoepidemiology and drug safety 20 (7), 772-777, 2011 | 197 | 2011 |
| Racial Disparities in the Risk of Developing Obesity-related Diseases H Zhang, R Rodriguez-Monguio Ethnicity & disease 22 (3), 308-316, 2012 | 114 | 2012 |
| The landscape of cellular and gene therapy products: authorization, discontinuations, and cost V Shukla, E Seoane-Vazquez, S Fawaz, L Brown, R Rodriguez-Monguio Human gene therapy clinical development 30 (3), 102-113, 2019 | 98 | 2019 |
| Ethical imperatives of timely access to orphan drugs: is possible to reconcile economic incentives and patients’ health needs? R Rodriguez-Monguio, T Spargo, E Seoane-Vazquez Orphanet journal of rare diseases 12, 1-8, 2017 | 89 | 2017 |
| Innovation and competition in advanced therapy medicinal products E Seoane‐Vazquez, V Shukla, R Rodriguez‐Monguio EMBO molecular medicine 11 (3), e9992, 2019 | 82 | 2019 |
| Exogenous endoscopy-related infections, pseudo-infections, and toxic reactions: clinical and economic burden E Seoane-Vazquez, R Rodriguez-Monguio, J Visaria, A Carlson Current medical research and opinion 22 (10), 2007-2021, 2006 | 75 | 2006 |
| Using a machine learning system to identify and prevent medication prescribing errors: a clinical and cost analysis evaluation R Rozenblum, R Rodriguez-Monguio, LA Volk, KJ Forsythe, S Myers, ... The Joint Commission Journal on Quality and Patient Safety 46 (1), 3-10, 2020 | 73 | 2020 |
| Injury during US Army basic combat training: a systematic review of risk factor studies MT Bulzacchelli, SI Sulsky, R Rodriguez-Monguio, LH Karlsson, ... American journal of preventive medicine 47 (6), 813-822, 2014 | 68 | 2014 |
| Approval and withdrawal of new antibiotics and other antiinfectives in the US, 1980–2009 K Outterson, JH Powers, E Seoane‐Vazquez, R Rodriguez‐Monguio, ... The Journal of Law, Medicine & Ethics 41 (3), 688-696, 2013 | 67 | 2013 |
| Endoscopy-related infections and toxic reactions: an international comparison E Seoane-Vazquez, R Rodriguez-Monguio, J Visaria, A Carlson Endoscopy 39 (08), 742-778, 2007 | 60 | 2007 |
| Endoscopy-related infection: relic of the past? E Seoane-Vazquez, R Rodriguez-Monguio Current opinion in infectious diseases 21 (4), 362-366, 2008 | 55 | 2008 |
| Incorporating medication indications into the prescribing process K Kron, S Myers, L Volk, A Nathan, P Neri, A Salazar, MG Amato, A Wright, ... The Bulletin of the American Society of Hospital Pharmacists 75 (11), 774-783, 2018 | 46 | 2018 |
| Fixed-dose combination drug approvals, patents and market exclusivities compared to single active ingredient pharmaceuticals J Hao, R Rodriguez-Monguio, E Seoane-Vazquez PloS one 10 (10), e0140708, 2015 | 44 | 2015 |
| Priority review drugs approved by the FDA and the EMA: time for international regulatory harmonization of pharmaceuticals? S Alqahtani, E Seoane‐Vazquez, R Rodriguez‐Monguio, T Eguale Pharmacoepidemiology and Drug Safety 24 (7), 709-715, 2015 | 44 | 2015 |
| Health information technologies: Which nursing homes adopted them? N Zhang, SF Lu, B Xu, B Wu, R Rodriguez-Monguio, J Gurwitz Journal of the American Medical Directors Association 17 (5), 441-447, 2016 | 43 | 2016 |
| Cost-effectiveness analysis of metformin+ dipeptidyl peptidase-4 inhibitors compared to metformin+ sulfonylureas for treatment of type 2 diabetes CS Kwon, E Seoane-Vazquez, R Rodriguez-Monguio BMC health services research 18, 1-12, 2018 | 38 | 2018 |
| Healthcare cost of type 1 diabetes mellitus in new-onset children in a hospital compared to an outpatient setting CF Jasinski, R Rodriguez-Monguio, K Tonyushkina, H Allen BMC pediatrics 13, 1-10, 2013 | 38 | 2013 |
| Evaluation of the expanded disability status scale and the multiple sclerosis functional composite as clinical endpoints in multiple sclerosis clinical trials: quantitative … A Bin Sawad, E Seoane-Vazquez, R Rodriguez-Monguio, F Turkistani Current Medical Research and Opinion 32 (12), 1969-1974, 2016 | 37 | 2016 |
Enrique Seoane VazquezChapman University School of PharmacyPotvrđena adresa e-pošte na chapman.edu
